Diabetes Patients on Semaglutide Had Fewer Fractures, Study Finds
CHICAGO — The GLP-1 receptor agonist semaglutide (Ozempic, Wegovy) was associated with a 15% lower risk for fractures in adults with type 2 diabetes, a review of medical records found.…
